These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34495476)

  • 1. Development of a fertility risk calculator to predict individualized chance of ovarian failure after chemotherapy.
    Chung EH; Acharya CR; Harris BS; Acharya KS
    J Assist Reprod Genet; 2021 Nov; 38(11):3047-3055. PubMed ID: 34495476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of age-specific risk prediction models for primary ovarian insufficiency in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study and St Jude Lifetime Cohort.
    Im C; Lu Z; Mostoufi-Moab S; Delaney A; Yu L; Baedke JL; Han Y; Sapkota Y; Yasui Y; Chow EJ; Howell RM; Bhatia S; Hudson MM; Ness KK; Armstrong GT; Nathan PC; Yuan Y
    Lancet Oncol; 2023 Dec; 24(12):1434-1442. PubMed ID: 37972608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of ovarian function in adolescents and young adults after childhood cancer treatment-How accurate are young adult/parent proxy-reported outcomes?
    George SA; Williamson Lewis R; McKenzie L; Cherven B; Patterson BC; Effinger KE; Mertens AC; Meacham LR
    Pediatr Blood Cancer; 2019 Dec; 66(12):e27981. PubMed ID: 31502374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting acute ovarian failure in female survivors of childhood cancer: a cohort study in the Childhood Cancer Survivor Study (CCSS) and the St Jude Lifetime Cohort (SJLIFE).
    Clark RA; Mostoufi-Moab S; Yasui Y; Vu NK; Sklar CA; Motan T; Brooke RJ; Gibson TM; Oeffinger KC; Howell RM; Smith SA; Lu Z; Robison LL; Chemaitilly W; Hudson MM; Armstrong GT; Nathan PC; Yuan Y
    Lancet Oncol; 2020 Mar; 21(3):436-445. PubMed ID: 32066539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.
    Suzuki N; Yoshioka N; Takae S; Sugishita Y; Tamura M; Hashimoto S; Morimoto Y; Kawamura K
    Hum Reprod; 2015 Mar; 30(3):608-15. PubMed ID: 25567618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary ovarian insufficiency in cancer survivors: Keys to optimal management.
    Garrido Colino C; González Urdiales P; Molinés Honrubia A; Ortega Acosta MJ; García Abos M
    An Pediatr (Engl Ed); 2023 Dec; 99(6):385-392. PubMed ID: 37993293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian function in female survivors of high-risk neuroblastoma.
    Jimenez-Kurlander L; DeRosa A; Kostrzewa CE; Moskowitz CS; Bogardus K; Antal Z; Wolden S; La Quaglia MP; Basu EM; Cardenas FI; Kramer K; Kushner BH; Cheung NV; Modak S; Friedman DN
    Pediatr Blood Cancer; 2024 Sep; 71(9):e31181. PubMed ID: 38967225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reproductive health outcomes in a cohort of young women with breast cancer exposed to systemic treatments.
    Silva C; Ribeiro Rama AC; Reis Soares S; Moura-Ramos M; Almeida-Santos T
    J Ovarian Res; 2019 Oct; 12(1):102. PubMed ID: 31672154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
    Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
    Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.
    Anderson RA; Mansi J; Coleman RE; Adamson DJA; Leonard RCF
    Eur J Cancer; 2017 Dec; 87():58-64. PubMed ID: 29117576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female adolescents and young women previously treated for pediatric malignancies: assessment of ovarian reserve and gonadotoxicity risk stratification for early identification of patients at increased infertility risk.
    Parissone F; Di Paola R; Balter R; Garzon S; Zaffagnini S; Neri M; Vitale V; Tridello G; Cesaro S
    J Pediatr Endocrinol Metab; 2021 Jan; 34(1):25-33. PubMed ID: 33068384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R).
    Choi MC; Chung YS; Lee JW; Kwon BS; Park BK; Kim SI; Shim SH; Lee KB; Seong SJ; Lee SJ; Lee SH; Yoo HJ; Song T; Kim MK; Baek MH; Kang S; Kim YM
    Eur J Cancer; 2020 Jul; 133():56-65. PubMed ID: 32442924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THERAPY OF ENDOCRINE DISEASE: Novel protection and treatment strategies for chemotherapy-associated ovarian damage.
    Xiong J; Xue L; Li Y; Tang W; Chen D; Zhang J; Dai J; Zhou S; Lu Z; Wu M; Wang S
    Eur J Endocrinol; 2021 May; 184(5):R177-R192. PubMed ID: 33630753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report From the St. Jude Lifetime Cohort.
    Chemaitilly W; Li Z; Krasin MJ; Brooke RJ; Wilson CL; Green DM; Klosky JL; Barnes N; Clark KL; Farr JB; Fernandez-Pineda I; Bishop MW; Metzger M; Pui CH; Kaste SC; Ness KK; Srivastava DK; Robison LL; Hudson MM; Yasui Y; Sklar CA
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2242-2250. PubMed ID: 28368472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Primary Ovarian Insufficiency Symptoms in Survivors of Childhood and Adolescent Cancer.
    Gargus E; Deans R; Anazodo A; Woodruff TK
    J Natl Compr Canc Netw; 2018 Sep; 16(9):1137-1149. PubMed ID: 30181423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility in adult women with classic galactosemia and primary ovarian insufficiency.
    van Erven B; Berry GT; Cassiman D; Connolly G; Forga M; Gautschi M; Gubbels CS; Hollak CEM; Janssen MC; Knerr I; Labrune P; Langendonk JG; Õunap K; Thijs A; Vos R; Wortmann SB; Rubio-Gozalbo ME
    Fertil Steril; 2017 Jul; 108(1):168-174. PubMed ID: 28579413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary ovarian insufficiency in an adolescent population: clinical phenotype and diagnostic approach.
    Hoyos-Martinez A; Hoyos LR; Comkornruecha M; Diaz A
    J Pediatr Endocrinol Metab; 2019 Sep; 32(9):979-985. PubMed ID: 31301677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.
    Senra JC; Roque M; Talim MCT; Reis FM; Tavares RLC
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):77-86. PubMed ID: 29055060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR.
    Pastore LM; Christianson MS; Stelling J; Kearns WG; Segars JH
    J Assist Reprod Genet; 2018 Jan; 35(1):17-23. PubMed ID: 28971280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographic, clinical and hormonal characteristics of patients with premature ovarian insufficiency and those of early menopause: data from two tertiary premature ovarian insufficiency centers in Greece.
    Bompoula MS; Valsamakis G; Neofytou S; Messaropoulos P; Salakos N; Mastorakos G; Kalantaridou SN
    Gynecol Endocrinol; 2020 Aug; 36(8):693-697. PubMed ID: 32208770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.